Form D · Venture Capital Fund
Ergo Bio Opportunity Investments, LP
San Jose, CA · CIK 0001971860
Offering snapshot reported Apr 3, 2023 · SEC filing
- Reported sold
- $221K Offering amount: $221K
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Mar 23, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2023 | Initial | $220,500 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477722
Source: Form D, filed Apr 3, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vandon Duong | Executive |
| N/A Ergo Bio Opportunity Management, Llc | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
559 Seven Trees Village Way
San Jose, CA, 95111
San Jose, CA, 95111